ES2426017A2 - Microemulsion comprising collagenase and uses (Machine-translation by Google Translate, not legally binding) - Google Patents

Microemulsion comprising collagenase and uses (Machine-translation by Google Translate, not legally binding) Download PDF

Info

Publication number
ES2426017A2
ES2426017A2 ES201200340A ES201200340A ES2426017A2 ES 2426017 A2 ES2426017 A2 ES 2426017A2 ES 201200340 A ES201200340 A ES 201200340A ES 201200340 A ES201200340 A ES 201200340A ES 2426017 A2 ES2426017 A2 ES 2426017A2
Authority
ES
Spain
Prior art keywords
collagenase
microemulsion
translation
machine
legally binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201200340A
Other languages
Spanish (es)
Other versions
ES2426017B1 (en
ES2426017R1 (en
Inventor
Juan Ramón MUÑOZ MONTAÑO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteos Biotech SL
Original Assignee
Proteos Biotech SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteos Biotech SL filed Critical Proteos Biotech SL
Priority to ES201200340A priority Critical patent/ES2426017B1/en
Publication of ES2426017A2 publication Critical patent/ES2426017A2/en
Publication of ES2426017R1 publication Critical patent/ES2426017R1/en
Application granted granted Critical
Publication of ES2426017B1 publication Critical patent/ES2426017B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Microemulsion comprising collagenase and uses. Microemulsion of recombinant collagenase g and recombinant collagenase h, pharmaceutical and cosmetic compositions, and its use in the treatment of cellulitis. (Machine-translation by Google Translate, not legally binding)
ES201200340A 2012-03-29 2012-03-29 Microemulsion comprising collagenase and uses Expired - Fee Related ES2426017B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201200340A ES2426017B1 (en) 2012-03-29 2012-03-29 Microemulsion comprising collagenase and uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201200340A ES2426017B1 (en) 2012-03-29 2012-03-29 Microemulsion comprising collagenase and uses

Publications (3)

Publication Number Publication Date
ES2426017A2 true ES2426017A2 (en) 2013-10-18
ES2426017R1 ES2426017R1 (en) 2013-11-27
ES2426017B1 ES2426017B1 (en) 2014-09-17

Family

ID=49274128

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201200340A Expired - Fee Related ES2426017B1 (en) 2012-03-29 2012-03-29 Microemulsion comprising collagenase and uses

Country Status (1)

Country Link
ES (1) ES2426017B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645668A (en) * 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
CN1579547A (en) * 2003-08-05 2005-02-16 上海乔源生物制药有限公司 Compound clostridiopeptidase compound emulsion and preparation method
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
WO2007100590A2 (en) * 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Methods for treating cellulite

Also Published As

Publication number Publication date
ES2426017B1 (en) 2014-09-17
ES2426017R1 (en) 2013-11-27

Similar Documents

Publication Publication Date Title
MX2016007063A (en) Therapeutic peptides.
CL2015000942A1 (en) Compounds of substituted benzene.
MY172578A (en) Oral dosing of glp-1 compounds
EA201590165A1 (en) CONTAINING ABUSE OF PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED LIBERATION
SA518391170B1 (en) Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
UA109464C2 (en) SPIROOXINDOL ANTAGONISTS MDM2
MX374785B (en) AFUCOSYLATED ANTI-FGFR2IIIB ANTIBODIES.
CL2016000807A1 (en) Amino heteroaryl benzamides as kinase inhibitors.
MX2016008448A (en) Var2csa-drug conjugates.
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
MX376058B (en) USE OF LONG-ACTING GLP-1 PEPTIDES.
CL2015000829A1 (en) Histone Demethylase Inhibitors
EP2558478A4 (en) MODIFIED PYRIMIDINES IN POSITION 5 AND THEIR USE
IN2015DN03029A (en)
JOP20140114B1 (en) Heterocyclic compounds and their uses
IN2014DN08721A (en)
CY1117214T1 (en) COMPOSITION FOR CONTROLLED OVENTION STUDY
EP4414376A3 (en) Novel depsipeptide and uses thereof
CL2015002897A1 (en) Bace1 inhibitors
CL2015001202A1 (en) Compounds derived from oxazolidin-2-one-pyrimidine; pharmaceutical composition and combination and use in the treatment of cancer.
BR112015013675A2 (en) compositions comprising vortioxetine and donepezil
CL2012003322A1 (en) Compounds derived from substituted benzamide; pharmaceutical composition; and use in the treatment of cancer.
UA117933C2 (en) A polypeptide capable of binding the C5 component of a human complement
EA201390955A1 (en) ROBO1-FC fusion protein for use in the treatment of hepatocarcinoma

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2426017

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20140917

FD2A Announcement of lapse in spain

Effective date: 20210915